Geneva Partners’s Marvell Technology MRVL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.7M Sell
40,657
-27,391
-40% -$6.14M 3.21% 8
2026
Q2
$20.3M Buy
+68,048
New +$13.6M 5.4% 2
2020
Q3
– Sell
-14,390
Closed -$505K – 90
2020
Q2
$505K Buy
+14,390
New +$421K 0.35% 57

Other funds holding MRVL

Geneva Partners's MRVL Position: Q3 2026 in Review

Geneva Partners reduced its Marvell Technology (MRVL) stake by 40% in Q3 2026, selling an estimated $6.14M and leaving 40,657 shares worth $10.7M. The position accounts for 3.21% of the portfolio, ranked #8.

Geneva Partners first reported a position in MRVL in Q2 2020 and has held it in 3 quarters since. The position peaked at $20.3M in Q2 2026. 748 funds tracked by Wall St. Rank hold MRVL as of Q3 2026.

  • Geneva Partners held 40,657 shares of Marvell Technology worth $10.7M as of Q3 2026.
  • Geneva Partners sold 27,391 Marvell Technology shares in Q3 2026, an estimated $6.14M.
  • Marvell Technology made up 3.21% of Geneva Partners's portfolio in Q3 2026, its #8 holding.
  • Geneva Partners first reported a position in Marvell Technology in Q2 2020 and has held it in 3 quarters since.
  • Geneva Partners's Marvell Technology position peaked at $20.3M in Q2 2026.
  • 748 funds tracked by Wall St. Rank held Marvell Technology as of Q3 2026.

Based on Geneva Partners's 13F filing for Q3 2026, filed 26 Oct 2026.